News

Filter

Current filters:

cariprazine

Positive mid-stage results for Forest Labs and Gedeon Richter’s cariprazine in MDD

21-03-2014

US drugmaker Forest Laboratories and Gedeon Richter, Hungary’s largest pharma company, have released…

cariprazineForest LaboratoriesGedeon RichterNeurologicalPharmaceuticalResearch

FDA calls for more info from Forest and Gedeon Richter on cariprazine

21-11-2013

The US Food and Drug Administration has issued a complete response letter regarding the New Drug Application…

cariprazineForest LaboratoriesGedeon RichterNeurologicalNorth AmericaPharmaceuticalRegulation

Forest Labs, Gedeon Richter plan 2012 filing for cariprazine

29-02-2012

Positive results from two phase III trials of Forest Laboratories and Gedeon Richter's new antipsychotic…

cariprazineForest LaboratoriesGedeon RichterHomeLexaproNamendaNeurologicalPharmaceutical

More strong data on Forest and Richter antipsychotic cariprazine

09-02-2012

US drugmaker Forest Laboratories (NYSE: FRX) has announced positive preliminary top-line results from…

cariprazineForest LaboratoriesGedeon RichterNeurologicalPharmaceuticalResearch

Setback for Forest Labs, as radiprodil disappoints in mid-stage pain trial

02-07-2010

USA-based Forest Laboratories and Hungary headquartered partner Gedeon Richter recently announced top-line…

cariprazineFinancialForest LaboratoriesGedeon RichterNeurologicalPharmaceuticalradiprodilResearch

COMPANY SPOTLIGHT

Menarini

Back to top